SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
milu
Lv4
470 积分
2024-02-01 加入
最近求助
最近应助
互助留言
Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
7天前
已完结
[Expert consensus on precise diagnosis and management of primary hepatocellular carcinoma in advanced stage (2023 version)]
8天前
已完结
Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China
8天前
已完结
Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis
13天前
已完结
Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more
13天前
已完结
Cost–effectiveness of second-line nivolumab for platinum-treated advanced non-small-cell lung cancer
13天前
已完结
Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan
23天前
已完结
Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-Line Treatment for Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
23天前
已完结
Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System
23天前
已完结
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia
23天前
已完结
没有进行任何应助
感谢,点赞,速度真快
8天前
感谢,点赞
13天前
感谢,点赞,速度真快
23天前
感谢,点赞,速度真快,帮大忙了
23天前
感谢,点赞,点赞,速度真快
1个月前
感谢,点赞,速度真快
1个月前
感谢
1个月前
好像没有正文
1个月前
感谢,点赞,点赞,速度真快,帮大忙了,么么哒
2个月前
速度真快,帮大忙了,点赞
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论